XML 53 R37.htm IDEA: XBRL DOCUMENT v3.22.4
Fair Value Measurements (Tables)
12 Months Ended
Jan. 28, 2023
Fair Value Disclosures [Abstract]  
Financial Assets And Liabilities Measured At Fair Value On Recurring Basis
Financial assets and liabilities measured at fair value on a recurring basis and cash equivalents held at amortized cost are as follows:
  
 Fair Value Measurements at Reporting Date Using
($ in millions)January 28, 2023Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets:
Cash equivalents$15 $— $15 $— 
Derivative financial instruments11 — 11 — 
Deferred compensation plan assets34 34 — — 
Other assets— — 
Total$64 $34 $26 $
Liabilities:
Derivative financial instruments$20 $— $20 $— 
  
 Fair Value Measurements at Reporting Date Using
($ in millions)January 29, 2022Quoted Prices in
Active Markets for
Identical Assets
(Level 1)
Significant Other
Observable Inputs
(Level 2)
Significant
Unobservable
Inputs
(Level 3)
Assets:
Cash equivalents$27 $— $27 $— 
Derivative financial instruments16 — 16 — 
Deferred compensation plan assets40 40 — — 
Other assets — — 
Total$87 $40 $43 $
Liabilities:
Derivative financial instruments$$— $$— 
Long Lived Assets Impairment [Table Text Block]
We recorded the following long-lived asset impairment charges in operating expenses on the Consolidated Statements of Operations:
Fiscal Year
($ in millions)202220212020
Operating lease assets (1)$33 $$391 
Store assets (2)18 135 
Other indefinite-lived intangible assets (3)— — 31 
Total impairment charges of long-lived and indefinite-lived assets$51 $$557 
__________
(1)The impairment charge reduced the then carrying amount of the applicable operating lease assets of $248 million, $24 million, and $1,635 million to their fair value of $215 million, $16 million, and $1,244 million during fiscal 2022, 2021, and 2020, respectively.
(2)The impairment charge reduced the then carrying amount of the applicable store assets of $21 million, $1 million, and $143 million to their fair value of $3 million, zero, and $8 million during fiscal 2022, 2021, and 2020, respectively.
(3)The impairment charge reduced the then carrying amount of the Intermix trade name of $38 million to its fair value of $7 million during fiscal 2020.